Metacrine

-$0.05 (-1.41%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Metacrine and other ETFs, options, and stocks.

About MTCR

Metacrine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapies for patients with liver and gastrointestinal (GI) diseases. It offers farnesoid X receptor (FXR), which is central to modulating liver and GI diseases.

CEO
Preston S. Klassen
Employees
35
Headquarters
San Diego, California
Founded
2014

MTCR Key Statistics

Market Cap
92.57M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
218.60K
High Today
$3.59
Low Today
$3.47
Open Price
$3.55
Volume
133.91K
52 Week High
$11.30
52 Week Low
$2.59

MTCR Earnings

-$1.41
-$0.94
-$0.47
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure